- Report
- December 2023
- 160 Pages
United States
From €2662EUR$2,789USD£2,230GBP
- Report
- March 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- January 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- February 2024
- 173 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 187 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- January 2022
- 100 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- January 2022
- 115 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 115 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 150 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- October 2023
- 181 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- December 2019
- 104 Pages
Asia Pacific
From €8585EUR$8,995USD£7,193GBP
- Report
- August 2022
- 100 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- May 2022
- 40 Pages
Argentina
From €1432EUR$1,500USD£1,199GBP
- Report
- May 2022
- 40 Pages
Poland
From €1432EUR$1,500USD£1,199GBP
From €1432EUR$1,500USD£1,199GBP
- Report
- May 2022
- 40 Pages
United Kingdom
From €1432EUR$1,500USD£1,199GBP
- Report
- May 2022
- 40 Pages
Vietnam
From €1432EUR$1,500USD£1,199GBP
- Report
- May 2022
- 40 Pages
United States
From €1432EUR$1,500USD£1,199GBP
- Report
- May 2022
- 40 Pages
South Korea
From €1432EUR$1,500USD£1,199GBP

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more